TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. PRENATAL SCREENING TESTS DEVICES MARKET,BY TEST
6.1. Overview
6.2. Alpha-Fetoprotein (AFP) Tests
6.3. Free Beta Human Chorionic Gonadotropin (hCG) Tests
6.4. Inhibin A Tests
6.5. Non-invasive prenatal testing (NIPT)
6.6. Pregnancy Associated Plasma Protein A (PAPP-A) Tests
6.7. Total Human Chorionic Gonadotropin (hCG) Tests
6.8. Unconjugated Estriol (uE3) Tests
7. PRENATAL SCREENING TESTS DEVICES MARKET, BY REGION
7.1. Overview
7.1. North America
7.1.1. US
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. France
7.2.3. UK
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest of Asia-Pacific
7.4. Rest of the World
7.4.1. Middle East
7.4.2. Africa
7.4.3. Latin America
8. COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Competitive Analysis
8.3. Market Share Analysis
8.4. Major Growth Strategy in the Prenatal screening tests devices market,
8.5. Competitive Benchmarking
8.6. Leading Players in Terms of Number of Developments in the Prenatal screening tests devices market,
8.7. Key developments and Growth Strategies
8.7.1. New ProductLaunch/Service Deployment
8.7.2. Merger &Acquisitions
8.7.3. Joint Ventures
8.8. Major Players Financial Matrix
8.8.1. Sales & Operating Income,2022
8.8.2. Major Players R&D Expenditure.2022
9. COMPANY PROFILES
9.1. Illumina Inc;
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Products Offered
9.1.4. Key Developments
9.1.5. SWOT Analysis
9.1.6. Key Strategies
9.2. BGI Genomics Co Ltd;
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Products Offered
9.2.4. Key Developments
9.2.5. SWOT Analysis
9.2.6. Key Strategies
9.3. Yourgene Health Plc;
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Products Offered
9.3.4. Key Developments
9.3.5. SWOT Analysis
9.3.6. Key Strategies
9.4. Eurofins Scientific SE;
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Products Offered
9.4.4. Key Developments
9.4.5. SWOT Analysis
9.4.6. Key Strategies
9.5. Agilent Technologies Inc;
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Products Offered
9.5.4. Key Developments
9.5.5. SWOT Analysis
9.5.6. Key Strategies
9.6. Roche Diagnostics International Ltd;
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Products Offered
9.6.4. Key Developments
9.6.5. SWOT Analysis
9.6.6. Key Strategies
9.7. PerkinElmer Inc;
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Products Offered
9.7.4. Key Developments
9.7.5. SWOT Analysis
9.7.6. Key Strategies
9.8. Beckman Coulter Inc;
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Products Offered
9.8.4. Key Developments
9.8.5. SWOT Analysis
9.8.6. Key Strategies
9.9. Abbott Laboratories;
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Products Offered
9.9.4. Key Developments
9.9.5. SWOT Analysis
9.9.6. Key Strategies
9.10. Siemens Healthineers AG.;
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Products Offered
9.10.4. Key Developments
9.10.5. SWOT Analysis
9.10.6. Key Strategies
9.11. Quidel Corp;
9.11.1. Company Overview
9.11.2. Financial Overview
9.11.3. Products Offered
9.11.4. Key Developments
9.11.5. SWOT Analysis
9.11.6. Key Strategies
9.12. Thermo Fisher Scientific Inc;
9.12.1. Company Overview
9.12.2. Financial Overview
9.12.3. Products Offered
9.12.4. Key Developments
9.12.5. SWOT Analysis
9.12.6. Key Strategies
9.13. Tosoh Corp;
9.13.1. Company Overview
9.13.2. Financial Overview
9.13.3. Products Offered
9.13.4. Key Developments
9.13.5. SWOT Analysis
9.13.6. Key Strategies
10. APPENDIX
10.1. References
10.2. Related Reports
LIST OF TABLES
TABLE 1 PRENATAL SCREENING TESTS DEVICES MARKET, SYNOPSIS, 2018-2032
TABLE 2 PRENATAL SCREENING TESTS DEVICES MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 PRENATAL SCREENING TESTS DEVICES MARKET,BY TEST, 2018-2032 (USD BILLION)
TABLE 4 NORTH AMERICA: PRENATAL SCREENING TESTS DEVICES MARKET,BY TEST, 2018-2032 (USD BILLION)
TABLE 5 US: PRENATAL SCREENING TESTS DEVICES MARKET,BY TEST, 2018-2032 (USD BILLION)
TABLE 6 CANADA: PRENATAL SCREENING TESTS DEVICES MARKET,BY TEST, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 2 GERMANY: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 3 FRANCE: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 4 ITALY: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 5 SPAIN: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 6 UK: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 7 REST OF EUROPE: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 8 ASIA-PACIFIC: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 9 JAPAN: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 10 CHINA: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 11 INDIA: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 12 AUSTRALIA: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 13 SOUTH KOREA: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 14 REST OF ASIA-PACIFIC: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 15 REST OF THE WORLD: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 16 MIDDLE EAST: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 17 AFRICA: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
TABLE 18 LATIN AMERICA: PRENATAL SCREENING TESTS DEVICES MARKET, BY TEST, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE PRENATAL SCREENING TESTS DEVICES MARKET
FIGURE 3 MARKET DYNAMICS FOR THE PRENATAL SCREENING TESTS DEVICES MARKET
FIGURE 4 PRENATAL SCREENING TESTS DEVICES MARKET, SHARE (%), BY TEST, 2022
FIGURE 5 PRENATAL SCREENING TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 6 NORTH AMERICA: PRENATAL SCREENING TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 EUROPE: PRENATAL SCREENING TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 ASIA-PACIFIC: PRENATAL SCREENING TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 REST OF THE WORLD: PRENATAL SCREENING TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 PRENATAL SCREENING TESTS DEVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 11 ILLUMINA INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 12 ILLUMINA INC: SWOT ANALYSIS
FIGURE 13 BGI GENOMICS CO LTD:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BGI GENOMICS CO LTD:SWOT ANALYSIS
FIGURE 15 YOURGENE HEALTH PLC:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 YOURGENE HEALTH PLC:SWOT ANALYSIS
FIGURE 17 EUROFINS SCIENTIFIC SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 EUROFINS SCIENTIFIC SE:SWOT ANALYSIS
FIGURE 19 AGILENT TECHNOLOGIES INC:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 AGILENT TECHNOLOGIES INC:SWOT ANALYSIS
FIGURE 21 ROCHE DIAGNOSTICS INTERNATIONAL LTD:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 ROCHE DIAGNOSTICS INTERNATIONAL LTD:SWOT ANALYSIS
FIGURE 23 PERKINELMER INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 PERKINELMER INC: SWOT ANALYSIS
FIGURE 25 BECKMAN COULTER INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 BECKMAN COULTER INC: SWOT ANALYSIS
FIGURE 27 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 29 SIEMENS HEALTHINEERS AG.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 SIEMENS HEALTHINEERS AG.:SWOT ANALYSIS
FIGURE 31 QUIDEL CORP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 QUIDEL CORP: SWOT ANALYSIS
FIGURE 33 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
FIGURE 35 TOSOH CORP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 TOSOH CORP: SWOT ANALYSIS
